SEMA3A and myeloid sarcoma: These results enlightened us about an unknown aspect of SEMA3A role in some autoimmune disorderslike multiple sclerosis (MS) and rheumatoid arthritis (RA) and also proposed SEMA3A as a potential therapeutic approach.